• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用机器学习和生存分析优化肝癌的预后预测

Optimizing Prognostic Predictions in Liver Cancer with Machine Learning and Survival Analysis.

作者信息

Cai Kaida, Fu Wenzhi, Wang Zhengyan, Yang Xiaofang, Liu Hanwen, Ji Ziyang

机构信息

Department of Epidemiology and Biostatistics, School of Public Health, Southeast University, Nanjing 210009, China.

Department of Statistics and Actuarial Science, School of Mathematics, Southeast University, Nanjing 211189, China.

出版信息

Entropy (Basel). 2024 Sep 7;26(9):767. doi: 10.3390/e26090767.

DOI:10.3390/e26090767
PMID:39330100
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11431161/
Abstract

This study harnesses RNA sequencing data from the Cancer Genome Atlas to unearth pivotal genetic markers linked to the progression of liver hepatocellular carcinoma (LIHC), a major contributor to cancer-related deaths worldwide, characterized by a dire prognosis and limited treatment avenues. We employ advanced feature selection techniques, including sure independence screening (SIS) combined with the least absolute shrinkage and selection operator (Lasso), smoothly clipped absolute deviation (SCAD), information gain (IG), and permutation variable importance (VIMP) methods, to effectively navigate the challenges posed by ultra-high-dimensional data. Through these methods, we identify critical genes like MED8 as significant markers for LIHC. These markers are further analyzed using advanced survival analysis models, including the Cox proportional hazards model, survival tree, and random survival forests. Our findings reveal that SIS-Lasso demonstrates strong predictive accuracy, particularly in combination with the Cox proportional hazards model. However, when coupled with the random survival forests method, the SIS-VIMP approach achieves the highest overall performance. This comprehensive approach not only enhances the prediction of LIHC outcomes but also provides valuable insights into the genetic mechanisms underlying the disease, thereby paving the way for personalized treatment strategies and advancing the field of cancer genomics.

摘要

本研究利用来自癌症基因组图谱的RNA测序数据,以发掘与肝细胞癌(LIHC)进展相关的关键基因标记。肝细胞癌是全球癌症相关死亡的主要原因,预后极差且治疗途径有限。我们采用先进的特征选择技术,包括确定性独立筛选(SIS)与最小绝对收缩与选择算子(Lasso)相结合、平滑截断绝对偏差(SCAD)、信息增益(IG)和排列变量重要性(VIMP)方法,以有效应对超高维数据带来的挑战。通过这些方法,我们确定了MED8等关键基因作为LIHC的重要标记。使用先进的生存分析模型,包括Cox比例风险模型、生存树和随机生存森林,对这些标记进行进一步分析。我们的研究结果表明,SIS-Lasso显示出强大的预测准确性,特别是与Cox比例风险模型结合时。然而,当与随机生存森林方法结合时,SIS-VIMP方法实现了最高的整体性能。这种综合方法不仅提高了对LIHC结果的预测,还为该疾病的潜在遗传机制提供了有价值的见解,从而为个性化治疗策略铺平道路,并推动癌症基因组学领域的发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3641/11431161/9da0bb64d55b/entropy-26-00767-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3641/11431161/3c63bb0281fb/entropy-26-00767-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3641/11431161/4e4b759cd82e/entropy-26-00767-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3641/11431161/4d3d23b04fc3/entropy-26-00767-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3641/11431161/aa6e104e8aae/entropy-26-00767-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3641/11431161/6fef37647716/entropy-26-00767-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3641/11431161/a572cbd966df/entropy-26-00767-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3641/11431161/9da0bb64d55b/entropy-26-00767-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3641/11431161/3c63bb0281fb/entropy-26-00767-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3641/11431161/4e4b759cd82e/entropy-26-00767-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3641/11431161/4d3d23b04fc3/entropy-26-00767-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3641/11431161/aa6e104e8aae/entropy-26-00767-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3641/11431161/6fef37647716/entropy-26-00767-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3641/11431161/a572cbd966df/entropy-26-00767-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3641/11431161/9da0bb64d55b/entropy-26-00767-g007.jpg

相似文献

1
Optimizing Prognostic Predictions in Liver Cancer with Machine Learning and Survival Analysis.利用机器学习和生存分析优化肝癌的预后预测
Entropy (Basel). 2024 Sep 7;26(9):767. doi: 10.3390/e26090767.
2
Combined Performance of Screening and Variable Selection Methods in Ultra-High Dimensional Data in Predicting Time-To-Event Outcomes.超高维数据中筛选和变量选择方法在预测事件发生时间结局方面的综合性能
Diagn Progn Res. 2018;2. doi: 10.1186/s41512-018-0043-4. Epub 2018 Sep 26.
3
Constructing and validating of m7G-related genes prognostic signature for hepatocellular carcinoma and immune infiltration: potential biomarkers for predicting the overall survival.构建和验证用于肝细胞癌的m7G相关基因预后特征及免疫浸润:预测总生存的潜在生物标志物
J Gastrointest Oncol. 2022 Dec;13(6):3169-3182. doi: 10.21037/jgo-22-1134.
4
Personalized prediction of survival rate with combination of penalized Cox models in patients with colorectal cancer.基于惩罚 Cox 模型组合的结直肠癌患者生存率个体化预测。
Medicine (Baltimore). 2024 Jun 14;103(24):e38584. doi: 10.1097/MD.0000000000038584.
5
Prognostic analysis of -related lncRNAs in liver hepatocellular carcinoma.肝细胞癌中与-相关的长链非编码RNA的预后分析。 (你提供的原文中“-related”这里有缺失信息,不太明确具体是什么相关,以上是按照补充完整后的大致翻译)
Ann Transl Med. 2022 Dec;10(24):1356. doi: 10.21037/atm-22-5827.
6
Identification of a Pyroptosis-Related Prognostic Signature Combined With Experiments in Hepatocellular Carcinoma.一种与细胞焦亡相关的预后特征的鉴定及其在肝细胞癌中的实验验证
Front Mol Biosci. 2022 Mar 4;9:822503. doi: 10.3389/fmolb.2022.822503. eCollection 2022.
7
System analysis based on the cuproptosis-related genes identifies LIPT1 as a novel therapy target for liver hepatocellular carcinoma.基于铜死亡相关基因的系统分析鉴定 LIPT1 为肝癌的一个新治疗靶点。
J Transl Med. 2022 Oct 4;20(1):452. doi: 10.1186/s12967-022-03630-1.
8
A signature based on neutrophil extracellular trap-related genes for the assessment of prognosis, immunoinfiltration, mutation and therapeutic response in hepatocellular carcinoma.基于中性粒细胞胞外诱捕网相关基因的signature 用于评估肝细胞癌的预后、免疫浸润、突变和治疗反应。
J Gene Med. 2024 Jan;26(1):e3588. doi: 10.1002/jgm.3588. Epub 2023 Sep 16.
9
Comprehensive analysis of N -methyladenosine-related long non-coding RNAs for prognosis prediction in liver hepatocellular carcinoma.全面分析 N -甲基腺苷相关长非编码 RNA 对肝癌的预后预测价值。
J Clin Lab Anal. 2021 Dec;35(12):e24071. doi: 10.1002/jcla.24071. Epub 2021 Nov 5.
10
Contributions and Prognostic Values of N6-Methyladenosine RNA Methylation Regulators in Hepatocellular Carcinoma.N6-甲基腺苷RNA甲基化调节因子在肝细胞癌中的作用及预后价值
Front Genet. 2021 Jan 15;11:614566. doi: 10.3389/fgene.2020.614566. eCollection 2020.

引用本文的文献

1
Integrating radiomics and machine learning for the diagnosis and prognosis of hepatocellular carcinoma.整合放射组学与机器学习用于肝细胞癌的诊断和预后评估
World J Gastrointest Oncol. 2025 Jul 15;17(7):106610. doi: 10.4251/wjgo.v17.i7.106610.
2
Comprehensive exploration of signal sequence receptor subunit 1 (SSR1) as a diagnostic and prognostic biomarker in liver hepatocellular carcinoma.信号序列受体亚基1(SSR1)作为肝细胞癌诊断和预后生物标志物的综合探索。
Am J Transl Res. 2025 Jan 15;17(1):560-584. doi: 10.62347/ANXV3598. eCollection 2025.

本文引用的文献

1
Global burden of liver cirrhosis and other chronic liver diseases caused by specific etiologies from 1990 to 2019.全球 1990 年至 2019 年因特定病因导致的肝硬化和其他慢性肝病负担。
BMC Public Health. 2024 Feb 3;24(1):363. doi: 10.1186/s12889-024-17948-6.
2
A Predictive Model for Prognosis and Therapeutic Response in Hepatocellular Carcinoma Based on a Panel of Three MED8-Related Immunomodulators.基于三种MED8相关免疫调节因子的肝细胞癌预后和治疗反应预测模型
Front Oncol. 2022 Apr 26;12:868411. doi: 10.3389/fonc.2022.868411. eCollection 2022.
3
SLC41A3 Exhibits as a Carcinoma Biomarker and Promoter in Liver Hepatocellular Carcinoma.
SLC41A3 作为肝癌的癌生物标志物和促进因子。
Comput Math Methods Med. 2021 Nov 15;2021:8556888. doi: 10.1155/2021/8556888. eCollection 2021.
4
High Expression of SLC41A3 Correlates with Poor Prognosis in Hepatocellular Carcinoma.SLC41A3的高表达与肝细胞癌的不良预后相关。
Onco Targets Ther. 2021 May 5;14:2975-2988. doi: 10.2147/OTT.S296187. eCollection 2021.
5
Review of statistical methods for survival analysis using genomic data.使用基因组数据进行生存分析的统计方法综述。
Genomics Inform. 2019 Dec;17(4):e41. doi: 10.5808/GI.2019.17.4.e41. Epub 2019 Dec 20.
6
Hepatocellular Carcinoma.肝细胞癌
N Engl J Med. 2019 Apr 11;380(15):1450-1462. doi: 10.1056/NEJMra1713263.
7
STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets.STRING v11:具有增强覆盖范围的蛋白质-蛋白质相互作用网络,支持在全基因组实验数据集的功能发现。
Nucleic Acids Res. 2019 Jan 8;47(D1):D607-D613. doi: 10.1093/nar/gky1131.
8
Burden of liver diseases in the world.世界范围内的肝脏疾病负担。
J Hepatol. 2019 Jan;70(1):151-171. doi: 10.1016/j.jhep.2018.09.014. Epub 2018 Sep 26.
9
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.帕博利珠单抗对比化疗用于 PD-L1 阳性非小细胞肺癌。
N Engl J Med. 2016 Nov 10;375(19):1823-1833. doi: 10.1056/NEJMoa1606774. Epub 2016 Oct 8.
10
Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks.用于具有竞争风险的删失事件时间的接收者操作特征曲线下时间依赖面积的估计与比较。
Stat Med. 2013 Dec 30;32(30):5381-97. doi: 10.1002/sim.5958. Epub 2013 Sep 12.